+905423212512 24/7 patient support
English
EUR
Gastroenterology

Cirrhosis Treatment in Turkey

Cirrhosis is a late stage of liver scarring caused by various long-term liver conditions and diseases. People often seek medical guidance when developing persistent fatigue, jaundice, unexplained weight loss, abdominal swelling, or easy bruising. Clinical management, lifestyle measures, and medical treatment options depend on a comprehensive specialist assessment to determine the extent of liver impairment. Compare hospitals in Turkey that treat Cirrhosis and get a free review of your medical records.

3 min read

Cirrhosis Treatment in Turkey
Price from
Price on request
Clinics
2

About Cirrhosis

Cirrhosis is a late stage of liver scarring caused by various long-term liver conditions and diseases. People often seek medical guidance when developing persistent fatigue, jaundice, unexplained weight loss, abdominal swelling, or easy bruising. Clinical management, lifestyle measures, and medical treatment options depend on a comprehensive specialist assessment to determine the extent of liver impairment.

Specialty: Gastroenterology

Best Clinics for Cirrhosis Treatment in Turkey

Frequently asked questions

The cost of treating Cirrhosis depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.

Cirrhosis is treated by Gastroenterology specialists. 2 clinics in Turkey on our platform offer this treatment.

What Cirrhosis Is and Typical Symptoms

Cirrhosis is an advanced stage of hepatic fibrosis where normal liver tissue is replaced by scar tissue and regenerative nodules. This structural alteration disrupts the liver's ability to process nutrients, filter metabolic waste, synthesise clotting proteins, and maintain vascular blood flow. Common causes include chronic hepatitis B or C, metabolic dysfunction-associated steatohepatitis (MASH), autoimmune liver disease, and long-term alcohol consumption.

In compensated cirrhosis, people may experience minimal symptoms, such as mild fatigue or nausea. As the condition progresses to decompensated cirrhosis, reduced hepatic function and portal hypertension cause more noticeable signs:

  • Jaundice: Yellowing of the eyes and skin due to accumulation of bilirubin.
  • Ascites and swelling: Fluid build-up in the abdomen and legs resulting from portal hypertension and decreased albumin levels.
  • Portal hypertension and varices: Elevated pressure in the portal venous system causing enlarged veins in the oesophagus and stomach that can bleed.
  • Hepatic encephalopathy: Cognitive changes, from poor concentration to acute confusion, caused by circulating toxins reaching the brain.
  • Easy bruising: Reduced production of clotting factors and spleen-related platelet reduction.

How Cirrhosis Is Diagnosed

International patients evaluated by a hospital department for gastroenterology undergo thorough clinical investigations. Doctors determine the degree of fibrosis, assess remaining functional capacity, identify underlying causes, and screen for liver cancer in conjunction with oncology specialists.

Diagnostic testing in Turkish hospitals typically includes:

  • Blood investigations: Liver function panels, bilirubin, albumin, international normalised ratio (INR), and viral hepatitis serologies to calculate MELD and Child-Pugh scores.
  • Transient elastography: Non-invasive FibroScan technology measuring liver tissue stiffness in kilopascals.
  • Diagnostic imaging: Ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) through dedicated check-ups and diagnostics services to assess liver texture, spleen size, and portal vein flow.
  • Upper endoscopy: Visualising oesophageal and gastric varices to evaluate haemorrhage risks.
  • Liver biopsy: Performed selectively if the cause of liver injury remains uncertain after imaging.

Patients should bring recent medical records, including laboratory reports, ultrasound or CT discs (DICOM format), endoscopy summaries, and a full list of current medications.

Treatment Options and When Each Is Used

Therapy focuses on halting disease progression, preventing decompensation, and managing secondary complications. Clinical decisions depend on whether liver damage is compensated or decompensated.

Option Typically used when Things to know
Targeted Medical Therapy Active hepatitis B or C, autoimmune liver disease, or metabolic liver disorders. Involves daily antivirals, immunosuppressants, or metabolic therapies to stabilise liver function.
Symptom Management Accumulation of ascites, peripheral oedema, or episodes of mild hepatic encephalopathy. Combines sodium-restricted diets, diuretics, lactulose, and non-absorbable intestinal antibiotics such as rifaximin.
Endoscopic Band Ligation Enlarged oesophageal varices at high risk of rupture or after acute variceal haemorrhage. Small elastic bands are placed over varices during an endoscopy; requires repeat sessions and beta-blockers.
TIPS Placement Severe ascites or recurrent variceal haemorrhage unresponsive to standard medical management. An interventional radiologist inserts a stent connecting portal and hepatic veins to lower portal venous pressure.
Transplant Evaluation End-stage liver disease or localised hepatocellular carcinoma within transplant criteria. Assessed with general surgery transplant teams; requires thorough clinical suitability checks and living-donor screening.

When liver disease involves alcohol dependence, ongoing support from psychiatry and addiction services is essential, as abstinence is vital for preventing further decompensation.

Planning Treatment in Turkey

Planning medical travel for cirrhosis requires thorough communication between overseas clinicians and your doctors at home. Turkish hospital teams evaluate prior medical documentation and imaging scans in advance to confirm your fitness for travel and outline appropriate assessments.

The length of your visit depends on the necessary procedures. Comprehensive diagnostic reviews and medical adjustments usually require four to six days. Interventional procedures, including variceal ligation or TIPS, generally require an inpatient stay followed by seven to ten days of local outpatient observation to ensure hemodynamic stability before air travel.

Before departure, ensure you obtain a comprehensive English discharge summary, including updated MELD scores and medication plans. You must coordinate ongoing care with your local hepatologist or general practitioner, including regular blood tests to monitor kidney function and electrolytes.

When Travel Is Not Advisable

Travelling abroad with severe liver dysfunction carries substantial medical hazards. Commercial air travel and changes in cabin pressure can worsen fluid retention and compromise stability. International travel should not be undertaken if cirrhosis is acutely decompensated or unmonitored.

Seek urgent emergency care locally if you experience any of these warning signs:

  • Gastrointestinal haemorrhage: Vomiting blood or passing black, tarry stools, indicating active variceal bleeding.
  • Acute confusion: Rapid onset of severe disorientation, memory loss, or extreme sleepiness characteristic of advanced encephalopathy.
  • Spontaneous bacterial peritonitis: High fever, chills, and severe abdominal pain in the presence of ascites.
  • Reduced urine output: A sudden decrease in urination, which may indicate acute renal impairment.
  • Severe breathlessness: Marked shortness of breath, which can occur with massive fluid retention.

All clinical care pathways and interventional treatments must be decided by your treating doctor following a thorough examination and review of your diagnostic results.

Frequently asked questions

Complete reversal of advanced cirrhosis is generally not possible once extensive fibrous scarring and architectural distortion have formed. However, prompt treatment targeting the underlying cause—such as antiviral therapy for hepatitis or complete alcohol abstinence—can halt disease progression. In some individuals with compensated cirrhosis, treating the primary condition may encourage partial regression of fibrosis and stabilisation of hepatic function, determined through regular specialist monitoring.

Compensated cirrhosis means the liver still maintains enough functional tissue to perform vital metabolic processes, often causing few or no obvious symptoms. Decompensated cirrhosis occurs when scarring compromises liver function to the point where major complications emerge. These include ascites, jaundice, hepatic encephalopathy, and bleeding from oesophageal varices. Decompensated cirrhosis carries higher clinical risks and necessitates close multidisciplinary management by hepatology and gastroenterology specialists.

Specialist doctors evaluate your fitness to travel through a remote assessment of recent medical history, blood results, and imaging scans. Key indicators include your MELD score, Child-Pugh class, presence of active ascites, and history of variceal bleeding or encephalopathy. Patients with stable, compensated disease are generally suitable for travel, whereas those with acute decompensation or recent haemorrhage are advised to avoid flights and seek immediate local care.

Nutrition plays a critical role in managing chronic liver disease and preventing muscle wasting. Patients are typically advised to maintain adequate protein and caloric intake while limiting sodium to manage fluid retention and ascites. Small, frequent meals and a late-evening carbohydrate snack help prevent protein breakdown overnight. Specific dietary guidelines, including vitamin supplementation, should always be tailored by your gastroenterology specialist or clinical dietitian based on individual blood tests.

Cirrhosis is the primary predisposing condition for hepatocellular carcinoma, the most common form of primary liver cancer. Because early-stage liver tumours rarely present with symptoms, routine surveillance allows for detection when localised treatments are most effective. International guidelines recommend an abdominal ultrasound and blood testing for alpha-fetoprotein (AFP) every six months. Your treating consultant will confirm the appropriate screening schedule based on your overall liver status and risk profile.

Free personalised quote